Nicotine Polacrilex
NDC Package 49226-873-05
Package Information
Nicotine Polacrilex is a . Marketed by Be Better Networks, this product is identified by NDC 49226-873 and is authorized under FDA application ANDA077007.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 49226 - Be Better Networks
- 49226-873 - Nicotine Polacrilex
- 49226-873-05 - 3 CONTAINER in 1 CARTON / 24 LOZENGE in 1 CONTAINER
- 49226-873 - Nicotine Polacrilex
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 49226-873-05 identifies a specific commercial package of 3 container in 1 carton / 24 lozenge in 1 container of Nicotine Polacrilex, labeled by Be Better Networks. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Be Better Networks on September 10, 2008. The current certification is valid through January 17, 2017.
How is this Be Better Networks product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 49226087305. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.